Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study. [electronic resource]
Producer: 20180426Description: 59 p. digitalISSN:- 1944-446X
- Adenovirus Vaccines -- administration & dosage
- Adult
- Aged
- Cancer Vaccines -- administration & dosage
- Carcinoma, Hepatocellular -- pathology
- Chemoembolization, Therapeutic -- methods
- Disease-Free Survival
- Female
- Humans
- Kaplan-Meier Estimate
- Liver Neoplasms -- pathology
- Male
- Middle Aged
- Neoplasm Staging
- Nomograms
- Prognosis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.